Mycoplasma pneumoniae Infection and Progressive Cold Agglutinin Syndrome in a Child: Catastrophic Multiple Cutaneous

Bahareh Abtahi-Naeini1,2, Sharareh Babaei3, Sayed Nassereddin Mostafavi4

  • 1Pediatric Dermatology Division of Department of Pediatrics, Imam Hossein Children's Hospital Isfahan University of Medical Sciences Isfahan Iran.

Clinical Case Reports
|August 29, 2025
PubMed

Insights

Acrocyanosis and gangrene in children with Catastrophe Syndrome (CAS) due to Mycoplasma pneumoniae (MP) infection are serious. Prompt supportive care, including FFP, plasmapheresis, corticosteroids, and IVIG, significantly improved the patient's condition.

Area of Science:

  • Pediatric infectious diseases
  • Hematology
  • Dermatology

Background:

  • Acrocyanosis and gangrene are rare but severe complications of Catastrophe Syndrome (CAS).
  • Mycoplasma pneumoniae (MP) infection is an identified cause of CAS in pediatric patients.
  • Timely recognition and management are crucial to prevent severe outcomes.

Purpose of the Study:

  • To report a case of CAS with acrocyanosis and gangrene in a child caused by MP infection.
  • To emphasize the importance of vigilant clinical monitoring and supportive care in such cases.
  • To illustrate the efficacy of specific therapeutic interventions.

Main Methods:

  • Case report detailing a pediatric patient with MP-induced CAS.
  • Description of clinical presentation including acrocyanosis and gangrene.
  • Documentation of treatment modalities administered.

Main Results:

  • The patient presented with severe manifestations of CAS, including acrocyanosis and gangrene.
  • Treatment involved the administration of fresh frozen plasma (FFP), plasmapheresis, corticosteroids, and intravenous immunoglobulin (IVIG).
  • A satisfactory improvement in the patient's clinical condition was observed post-treatment.

Conclusions:

  • MP infection can precipitate CAS, leading to critical acrocyanosis and gangrene in children.
  • Aggressive supportive care, incorporating FFP, plasmapheresis, corticosteroids, and IVIG, can lead to favorable outcomes.
  • Clinicians must maintain a high index of suspicion and provide prompt, comprehensive management for pediatric CAS.